In This Section

AACR Princess Takamatsu Memorial Lectureship

Nomination StatusOpen
Nomination DeadlineSeptember 30, 2021
Generously Supported ByThe Princess Takamatsu Cancer Research Fund (Japan)
Description

The AACR and the Princess Takamatsu Cancer Research Fund established this lectureship in 2007 in honor of the late Imperial Highness Princess Takamatsu. The lectureship is intended to recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer, and who embodies the dedication shown by Princess Takamatsu to multinational collaborations.

Eligibility Criteria

Cancer researchers affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may be nominated. Such institutions include those in academia, industry, or government.

The Lectureship may only be presented to an individual investigator.

Institutions and/or organizations are not eligible to receive the Lectureship.

Contact Information

Please direct all inquiries pertaining to this award or any other AACR scientific achievement award or lecture to Michael J. Powell, PhD, Deputy Director of Scientific Programs, at [email protected] or by phone at (215) 440-9373.

Nomination Criteria

Nominations may be submitted by any individual, whether an AACR member or nonmember, who is currently or has previously been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science.

Self-nominations are prohibited.

Nominators must maintain strict confidentiality of their nominations and all nominations must be submitted electronically to https://myaacr.aacr.org. Paper nominations will not be accepted.

Eligible nominations must include the following:

  • A nomination letter written in English (Max: 1,000 words), which comprehensively describes the candidate's novel and significant work in cancer research and dedication to multinational collaborations. Letter must specifically outline the candidate’s current research activity and indicate how their research holds promise for continued substantive contributions to the cancer field. All publications that directly support the mentioned research accomplishments must be referenced within the provided letter.
  • A brief scientific citation (Max: 50 words) highlighting the major scientific contribution(s) justifying the award candidate’s nomination.
  •  

See the Program Guidelines and Nomination Instructions for details.

Selection Process

Eligible nominees will be considered by an Award Selection Committee composed of an international cohort of cancer research experts appointed by the AACR President. After Award Committee deliberations, primary and alternate award recipient recommendations will be relayed to the AACR Executive Committee for formal ratification.

Selection of the Award recipient shall be made on the basis of the candidate's scientific accomplishments without regard to race, gender, nationality, geographic location, or religious or political views.